🇺🇸 FDA

Company profile · Sponsor

TScan

TScan Therapeutics

TCRX · NYSE biotech WALTHAM, MA, USA
Pipeline
9
Drugs
0
Patents
0

Quick answer

TScan (TCRX) is a biotech company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker TCRX
Exchange NYSE
Company type biotech
Headquarters WALTHAM, MA, USA
SEC CIK 0001783328

Pipeline (9)

Search pipeline →

  1. KSH01 injection

    TScan

    Solid Tumor

    phase 1 small molecule active

    1 trial

  2. KSH01 injection

    TScan

    TCR-T Cells

    phase 1 small molecule active

    1 trial

  3. KSV01 Injection

    TScan

    B-ALL

    phase 1 small molecule active

    1 trial

  4. KSV01 Injection

    TScan

    Non-Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  5. KSX01-TCRT injection

    TScan

    TCR-T Cells

    phase 1 small molecule active

    1 trial

  6. KXV01 TCR Lentinvivo Injection

    TScan

    Advanced Solid Tumors

    phase 1 small molecule active

    2 trials

  7. SOC + TSC-100

    TScan

    AML

    phase 1 small molecule active

    1 trial

  8. TSC-204-A0201

    TScan

    Head and Neck Cancer

    phase 1 mab active

    1 trial

  9. Tcrx T cell

    TScan

    Gastric Cancer

    phase 1 mab active

    1 trial

Frequently asked questions

What is TScan?

TScan (TCRX) is a biotech company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does TScan sponsor?

We track 9 ClinicalTrials.gov-linked programs for TScan, including KSH01 injection and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does TScan company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.